Related Experiment Video
Updated: Jul 18, 2026
14:33
Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species
Published on: August 30, 2012
Gerstmann-Sträussler-Scheinker disease. I. Human diseases
Paweł P Liberski1, Herbert Budka
1Department of Molecular Pathology and Neuropathology, Medical University of Lódź, Poland. ppliber@csk.am.lodz.pl
Folia Neuropathologica
|August 15, 2006
Summary
Gerstmann-Sträussler-Scheinker disease (GSS) is a rare, inherited neurodegenerative disorder. This review summarizes GSS family data, neuropathology, and insights from transgenic mouse models of prion protein mutations.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Gerstmann-Sträussler-Scheinker disease (GSS) is a rare, autosomal dominant inherited neurodegenerative disorder.
- It is the first human transmissible spongiform encephalopathy (TSE) linked to prion protein (PrP) gene mutations.
- GSS prevalence is estimated between 1-10 per 100,000,000, with diagnosis defined by progressive ataxia/dementia and specific neuropathology.
Purpose of the Study:
- To review all documented families with Gerstmann-Sträussler-Scheinker disease.
- To consolidate neuropathological findings, particularly multi-centric prion plaques.
- To summarize experimental data from transgenic mouse models and structural biology of mutated PrP.
Main Methods:
- Comprehensive literature review of GSS family cases.
- Analysis of neuropathological characteristics, focusing on PrP plaque morphology.
- Summary of findings from experimental models, including transgenic mice expressing mutated PrP.
Main Results:
- GSS is characterized by multi-centric prion protein (PrP) plaques, though patterns vary among families.
- Mutations in the PrP gene are causative, leading to autosomal dominant inheritance.
- Transgenic mouse models provide insights into GSS pathogenesis and the structural biology of mutated PrP.
Conclusions:
- GSS represents a key model for understanding inherited prion diseases.
- Neuropathological hallmarks and genetic mutations are crucial for diagnosis and research.
- Experimental models are vital for elucidating the molecular mechanisms underlying GSS.
More Related Videos
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...